In the contemporary U.S. healthcare landscape, the health insurance market has become increasingly consolidated, with a few major payers commanding substantial market share. According to the American Medical Association’s 2025 Competition in Health Insurance: A Comprehensive Study of U.S. Markets (analyzing 2024 data), 97% of commercial health insurance markets at the metropolitan level were classified as highly concentrated (HHI > 1,800), up from 95% in 2014.[^1][^2] In nearly half (47%) of these markets, a single insurer controlled at least 50% of the share.[^1] This consolidation grants insurers significant negotiating leverage, profoundly affecting reimbursement rates, administrative processes, and practice sustainability for orthopedic and spine surgeons.
Key Challenges
Insurance market dominance has led to declining reimbursement rates for physicians. With enhanced monopsony power, major payers can dictate lower payments to providers while facing limited risk of losing network participation. This pressure is compounded by ongoing Medicare fee schedule reductions; the 2025 physician fee schedule conversion factor was cut by approximately 2.83%, contributing to a broader trend of inflation-adjusted reimbursement declines in orthopedics and spine care.
The Geographic Variable: State-Level Monopolies and Reimbursement Barriers
While market dominance is a national trend, the impact on orthopedic and spine surgeons is acutely felt at the state level, where insurance landscapes vary significantly. The degree of payor concentration in a specific region dictates the feasibility of certain surgical models, particularly for those performing high-complexity cases in Ambulatory Surgery Centers (ASCs).A prime example of this regional disparity can be seen in Alabama, which ranks as the least competitive commercial health insurance market in the United States per the AMA’s 2025 report.[^3] Blue Cross Blue Shield of Alabama dominates with approximately 86% of the commercial market (higher in certain segments and metro areas).[^4][^5] In such a highly concentrated environment, the power dynamic shifts entirely toward the payor. Surgeons lose leverage to negotiate fair market rates, and the payor’s policies effectively become the “law of the land” for medical practice.This dominance has direct consequences for innovation and site-of-service shifts. For instance, if a dominant payor like BCBS Alabama chooses not to adequately reimburse for implants in an ASC setting—often bundling them into the facility fee at rates that fail to cover costs—routine spine cases requiring hardware, such as Anterior Cervical Discectomy and Fusion (ACDF) or Cervical Disc Arthroplasty (CDA), become financially non-viable. Surgeons commonly report that implant costs can exceed the total reimbursement by 20–30% without a dedicated carve-out or pass-through payment, forcing these cases back to the more expensive hospital setting.For spine surgeons, navigating these challenges requires a granular understanding of the local market. Before investing in ASC infrastructure or transitioning to a specialized outpatient model, surgeons must ask critical questions:
- Is there any market competition to leverage? In states like Alabama, the lack of a secondary or tertiary payor means surgeons cannot “walk away” from a bad contract, as there are no other patient pools to sustain the practice.
- Does the dominant payor provide a “carve-out” for implants? Without separate reimbursement for high-cost hardware, the ASC facility fee is often insufficient to cover overhead.
- What is the payor’s stance on Cervical Disc Arthroplasty in the outpatient setting? Some monopolies may lag behind clinical evidence, categorizing outpatient disc replacements as “investigational” or refusing sustainable coding/reimbursement.
Why Alabama Surgeons Face Unique Challenges
In contrast, more competitive states like Washington or Oregon often see the largest payer holding <25% share, giving providers greater bargaining power and flexibility for ASC transitions. Ultimately, the ability to offer advanced spine care in a cost-effective surgery center is not just a matter of surgical skill or facility efficiency; it is a matter of market geography. Surgeons must perform due diligence on state-specific insurance monopolies to determine if their clinical goals are even financially possible.
State Breakdown of the Commercial Insurance Market: Impact on Ortho and Spine Surgeons
Market consolidation at the state level has created a significant power imbalance. The AMA’s 2025 report identifies the following as the 10 states with the least competitive commercial health insurance markets (ranked by concentration/HHI in combined PPO+HMO+POS+exchange markets):[^3]
| Rank | State | Dominant Payer | Approx. Largest Insurer Share (2024) | Notes |
|---|---|---|---|---|
| 1 | Alabama | Blue Cross Blue Shield of Alabama | ~86% | Highest concentration nationally[^4][^5] |
| 2 | Kentucky | Elevance Health (Anthem) | ~67% | Strong regional dominance |
| 3 | Hawaii | HMSA / BCBS affiliate | High (~63%) | Island geography limits competition |
| 4 | Michigan | Blue Cross Blue Shield of Michigan | ~67% | BCBS leads in many segments |
| 5 | Louisiana | Blue Cross Blue Shield of Louisiana | ~66% | Significant monopsony power |
| 6 | Illinois | Health Care Service Corp. (HCSC) | ~63% | Multi-state Blues influence |
| 7 | Alaska | Premera Blue Cross | High (~46–79% in reports) | Remote market challenges |
| 8 | Vermont | BCBS of Vermont | High | Small population, limited entrants |
| 9 | Delaware | Highmark / others | High | Northeast concentration |
| 10 | West Virginia | Highmark / others | High | Rural market dynamics |
In these regions, orthopedic and spine surgeons often face “take it or leave it” scenarios. Because one carrier controls the vast majority of the patient population, surgeons have virtually zero leverage to negotiate fair reimbursement rates.
Direct Consequences for Specialty Surgery
- Erosion of Bargaining Power: In highly concentrated markets like Alabama or Michigan, dominant insurers can unilaterally freeze or decrease reimbursement rates. For spine surgeons, this is particularly challenging as it fails to account for rising costs of specialized implants and hardware.
- Aggressive Prior Authorization: Dominant payers use their market position to implement more rigorous prior authorization hurdles. This often results in clinical delays for patients requiring spinal fusions or joint replacements, increasing administrative burden.
- Forced Site-of-Service Shifting: In many states, dominant insurers mandate procedures move to ASCs. While efficient, reimbursements often fail to reflect the complexity of high-acuity spine/ortho cases.
- Narrow Networks: Dominant carriers narrow networks, excluding specialists and forcing patients to travel or pay out-of-network costs.
Nationally, Blue Cross Blue Shield affiliates remain the largest player in 43 states and 84% of metro areas (combined 43% national share).[^1][^6] UnitedHealth Group holds the largest individual commercial share (16%), followed by Elevance Health and CVS/Aetna (both ~12%).[^1]
“When one or two companies control the market, premiums go up, choices shrink, and physicians lose their clinical autonomy to determine the best care for their patients.” — AMA 2025 Competition Analysis.[^2]
Escalating prior authorization requirements burden high-cost procedures like joint replacements, spinal fusions, and advanced imaging—often delaying care without clear cost reductions.
Medicare Advantage plans exacerbate issues, denying routine services more aggressively than traditional Medicare.These pressures accelerate consolidation, pushing independent ortho/spine practices toward hospital systems, larger groups, or private equity.
Opportunities Amidst Adversity
Despite hurdles, adaptive surgeons can build resilience:
- Migrate high-volume, lower-acuity cases to ASCs for lower overhead and efficiency (where reimbursements support it).
- Pursue strategic consolidation (e.g., larger independent groups or MSO partnerships) to improve negotiating power.
- Innovate care delivery models tailored to local payer dynamics.
Conclusion
The dominance of major health insurers imposes considerable strain on orthopedic and spine surgeons through reduced reimbursements, rigorous prior authorizations, and administrative complexities. However, proactive strategies—such as transitioning to ASCs (with careful market vetting), pursuing thoughtful consolidation, and innovating care delivery—enable surgeons to mitigate challenges and capitalize on opportunities for professional growth and improved patient care.
Data as of the AMA’s December 2025 Competition in Health Insurance report (2024 enrollment); local markets can shift with new entrants or policy changes.
Drew Albert, MD — OrthoAndSpineJobs.com connects orthopedic and spine surgeons with career opportunities in independent practices, large groups, and innovative settings. Visit for the latest job openings.
References
[^1]: American Medical Association. (2025).
Competition in Health Insurance: A Comprehensive Study of U.S. Markets
[^2]: AMA Press Release: Health insurance giants tighten grip on U.S. markets (Dec 16, 2025).
[^3]: AMA. (2025). Top 10 least competitive commercial markets (from report appendices/summaries).
[^4]: Becker’s Payer Issues. (2024). The largest commercial insurer in every state.
[^5]: Visual Capitalist / AMA data. (2024). Mapped: The Top Health Insurance Companies by State.
[^6]: AMA. (2025). BCBS dominance in states and MSAs (from report and press materials).
